MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Das könnte Ihnen auch gefallen
Gewinner
Neueste Krypto-Nachrichten
24-Stunden Spot Funding Zu-/Abflussliste: ETH Nettoabfluss von 126 Mio. $, ZEC Nettoabfluss von 18,2 Mio. $
Bloomberg: Fed spaltet sich bei langfristiger Zinsstrategie nie so sehr
Schlüsseltransaktionsdaten: US 10-jährige Treasury-Rendite steigt auf 4,086%
Mainstream Perp DEX Übersicht: Hyperliquid übersteigt erneut Handelsvolumen von 10 Milliarden US-Dollar, Plattformvolumen erholt sich gemeinsam
Die European Stablecoin Alliance ernennt ehemaligen Coinbase Executive zum Chief Executive Officer
Kundenservice:@weikecs
Geschäftliche Zusammenarbeit:@weikecs
Quant-Trading & MM:[email protected]
VIP-Services:[email protected]